The effectiveness of retreatment with peginterferon alfa and ribavirin in patients with chronic viral hepatitis C genotype 2 and 3: a prospective cohort study in Brazil

BACKGROUND: More than 50% of patients infected with chronic hepatitis C virus (HCV) do not respond to treatment with conventional interferon (IFN) combined with ribavirin (RBV). The aim of our study was to evaluate the effectiveness of retreatment with peginterferon alfa-2a or 2b (PEG-IFN 2a or 2b)...

Descripción completa

Detalles Bibliográficos
Autores principales: Artico, Simara, Amaral, Karine Medeiros, Gonçalves, Candice Beatriz Treter, Picon, Paulo Dornelles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3548710/
https://www.ncbi.nlm.nih.gov/pubmed/23270376
http://dx.doi.org/10.1186/1471-2334-12-377

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3548710/
https://www.ncbi.nlm.nih.gov/pubmed/23270376
http://dx.doi.org/10.1186/1471-2334-12-377

Ejemplares similares